Noramco is a specialty pharmaceutical company focused on active pharmaceutical ingredient (API) development and manufacturing. It supports the advancement of opioid and non-opioid products, with expertise in controlled substances from development through large-scale supply and formulation-ready particle size options. Headquartered in Delaware with global operations, Noramco emphasizes DEA-compliant production, high-purity APIs, and regulatory readiness to serve the pharmaceutical industry. The company positions itself as a leader in addiction treatment and abuse prevention through its nal-family compounds and ADHD-related APIs.
No recent news for this company.